Investors question Nestlé CHC move
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Swiss food and drinks giant Nestlé should “better explain to shareholders the rationale behind expanding further into consumer healthcare”,says major shareholder Third Point.
You may also be interested in...
Hershey's Latest Sweet Spot In Nutritional Space: $397m For One Brands
Marketer long known for iconic Hershey's Kisses and other candy products looks to grow its nutritional market revenues with One Brands' products, complementing its Oatmega business and following its investment earlier in August in UK/Ireland maker of protein bars.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.